# Lonza increases contract production of Portola's AndexXa

Lonza will increase contract production of Portola Pharmaceuticals' AndexXa at its Visp, Switzerland plant, joining its Porrino, Spain facility.

- Type: Contract
- Announced: 2017-09-11
- Where: Visp, Switzerland, Switzerland
- Status: announced
- Products: AndexXa (modified human Factor Xa)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Lonza Group AG](https://endata.com/companies/20735.md)
- [Portola Pharmaceuticals](https://endata.com/companies/26870.md) (customer)

## Sources

- [cen.acs.org](https://cen.acs.org/articles/95/i36/Business-Roundup.html), 2017-09-11: "Lonza will increase contract production of Portola Pharmaceuticals’ AndexXa."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.